當(dāng)前位置：首頁(yè) JCRQ2 期刊介紹(非官網(wǎng))

Drug Testing And AnalysisSCIE

國(guó)際簡(jiǎn)稱：DRUG TEST ANAL 參考譯名：藥物檢測(cè)與分析

中科院分區(qū)
3區(qū)
CiteScore分區(qū)
Q2
JCR分區(qū)
Q2

基本信息：: ISSN：1942-7603; E-ISSN：1942-7611; 是否OA：未開放; 是否預(yù)警：否; TOP期刊：否

出版信息：: 出版地區(qū)：ENGLAND; 出版商：John Wiley and Sons Ltd; 出版語(yǔ)言：English; 出版周期：Bimonthly; 出版年份：2009; 研究方向：BIOCHEMICAL RESEARCH METHODS-CHEMISTRY, ANALYTICAL

評(píng)價(jià)信息：: 影響因子：2.6; H-index：44; CiteScore指數(shù)：5.9; SJR指數(shù)：0.833; SNIP指數(shù)：0.942

發(fā)文數(shù)據(jù)：: Gold OA文章占比：35.42%; 研究類文章占比：95.18%; 年發(fā)文量：166; 自引率：0.2413...; 開源占比：0.2336; 出版撤稿占比：0; 出版國(guó)人文章占比：0.05; OA被引用占比：0.0587...

投稿咨詢加急見刊

英文簡(jiǎn)介期刊介紹 CiteScore數(shù)據(jù) 中科院SCI分區(qū) JCR分區(qū) 發(fā)文數(shù)據(jù) 常見問(wèn)題

英文簡(jiǎn)介Drug Testing And Analysis期刊介紹

As the incidence of drugs escalates in 21st century living, their detection and analysis have become increasingly important. Sport, the workplace, crime investigation, homeland security, the pharmaceutical industry and the environment are just some of the high profile arenas in which analytical testing has provided an important investigative tool for uncovering the presence of extraneous substances.

In addition to the usual publishing fare of primary research articles, case reports and letters, Drug Testing and Analysis offers a unique combination of; ‘How to’ material such as ‘Tutorials’ and ‘Reviews’, Speculative pieces (‘Commentaries’ and ‘Perspectives', providing a broader scientific and social context to the aspects of analytical testing), ‘Annual banned substance reviews’ (delivering a critical evaluation of the methods used in the characterization of established and newly outlawed compounds).

Rather than focus on the application of a single technique, Drug Testing and Analysis employs a unique multidisciplinary approach to the field of controversial compound determination. Papers discussing chromatography, mass spectrometry, immunological approaches, 1D/2D gel electrophoresis, to name just a few select methods, are welcomed where their application is related to any of the six key topics listed below.

期刊簡(jiǎn)介Drug Testing And Analysis期刊介紹

《Drug Testing And Analysis》自2009出版以來(lái)，是一本醫(yī)學(xué)優(yōu)秀雜志。致力于發(fā)表原創(chuàng)科學(xué)研究結(jié)果，并為醫(yī)學(xué)各個(gè)領(lǐng)域的原創(chuàng)研究提供一個(gè)展示平臺(tái)，以促進(jìn)醫(yī)學(xué)領(lǐng)域的的進(jìn)步。該刊鼓勵(lì)先進(jìn)的、清晰的闡述，從廣泛的視角提供當(dāng)前感興趣的研究主題的新見解，或?qū)彶槎嗄陙?lái)某個(gè)重要領(lǐng)域的所有重要發(fā)展。該期刊特色在于及時(shí)報(bào)道醫(yī)學(xué)領(lǐng)域的最新進(jìn)展和新發(fā)現(xiàn)新突破等。該刊近一年未被列入預(yù)警期刊名單，目前已被權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，得到了廣泛的認(rèn)可。

該期刊投稿重要關(guān)注點(diǎn)：

預(yù)計(jì)審稿時(shí)間：約3.0個(gè)月
醫(yī)學(xué)
BIOCHEMICAL RESEARCH METHODS
SCIE
中科院3區(qū)
非預(yù)警

Cite Score數(shù)據(jù)（2024年最新版）Drug Testing And Analysis Cite Score數(shù)據(jù)

CiteScore：5.9
SJR：0.833
SNIP：0.942

學(xué)科類別	分區(qū)	排名	百分位
大類：Chemistry 小類：Analytical Chemistry	Q2	49 / 156	68%
大類：Chemistry 小類：Pharmaceutical Science	Q2	58 / 183	68%
大類：Chemistry 小類：Spectroscopy	Q2	27 / 76	65%
大類：Chemistry 小類：Environmental Chemistry	Q2	62 / 147	58%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評(píng)價(jià)期刊影響力的文獻(xiàn)計(jì)量指標(biāo)。反映出一家期刊近期發(fā)表論文的年篇均引用次數(shù)。CiteScore以Scopus數(shù)據(jù)庫(kù)中收集的引文為基礎(chǔ)，針對(duì)的是前四年發(fā)表的論文的引文。CiteScore的意義在于，它可以為學(xué)術(shù)界提供一種新的、更全面、更客觀地評(píng)價(jià)期刊影響力的方法，而不僅僅是通過(guò)影響因子(IF)這一單一指標(biāo)來(lái)評(píng)價(jià)。

歷年Cite Score趨勢(shì)圖

中科院SCI分區(qū)Drug Testing And Analysis 中科院分區(qū)

中科院 2023年12月升級(jí)版 綜述期刊：否 Top期刊：否

大類學(xué)科	分區(qū)	小類學(xué)科	分區(qū)
醫(yī)學(xué)	3區(qū)	BIOCHEMICAL RESEARCH METHODS 生化研究方法 CHEMISTRY, ANALYTICAL 分析化學(xué) PHARMACOLOGY & PHARMACY 藥學(xué)	2區(qū) 2區(qū) 3區(qū)

中科院分區(qū)表 是以客觀數(shù)據(jù)為基礎(chǔ)，運(yùn)用科學(xué)計(jì)量學(xué)方法對(duì)國(guó)際、國(guó)內(nèi)學(xué)術(shù)期刊依據(jù)影響力進(jìn)行等級(jí)劃分的期刊評(píng)價(jià)標(biāo)準(zhǔn)。它為我國(guó)科研、教育機(jī)構(gòu)的管理人員、科研工作者提供了一份評(píng)價(jià)國(guó)際學(xué)術(shù)期刊影響力的參考數(shù)據(jù)，得到了全國(guó)各地高校、科研機(jī)構(gòu)的廣泛認(rèn)可。

中科院分區(qū)表 將所有期刊按照一定指標(biāo)劃分為1區(qū)、2區(qū)、3區(qū)、4區(qū)四個(gè)層次，類似于“優(yōu)、良、及格”等。最開始，這個(gè)分區(qū)只是為了方便圖書管理及圖書情報(bào)領(lǐng)域的研究和期刊評(píng)估。之后中科院分區(qū)逐步發(fā)展成為了一種評(píng)價(jià)學(xué)術(shù)期刊質(zhì)量的重要工具。

歷年中科院分區(qū)趨勢(shì)圖

JCR分區(qū)Drug Testing And Analysis JCR分區(qū)

2023-2024 年最新版

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：BIOCHEMICAL RESEARCH METHODS	SCIE	Q2	42 / 85	51.2%
學(xué)科：CHEMISTRY, ANALYTICAL	SCIE	Q2	53 / 106	50.5%
學(xué)科：PHARMACOLOGY & PHARMACY	SCIE	Q2	173 / 354	51.3%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：BIOCHEMICAL RESEARCH METHODS	SCIE	Q2	33 / 85	61.76%
學(xué)科：CHEMISTRY, ANALYTICAL	SCIE	Q2	38 / 106	64.62%
學(xué)科：PHARMACOLOGY & PHARMACY	SCIE	Q2	136 / 354	61.72%

JCR分區(qū)的優(yōu)勢(shì)在于它可以幫助讀者對(duì)學(xué)術(shù)文獻(xiàn)質(zhì)量進(jìn)行評(píng)估。不同學(xué)科的文章引用量可能存在較大的差異，此時(shí)單獨(dú)依靠影響因子(IF)評(píng)價(jià)期刊的質(zhì)量可能是存在一定問(wèn)題的。因此，JCR將期刊按照學(xué)科門類和影響因子分為不同的分區(qū)，這樣讀者可以根據(jù)自己的研究領(lǐng)域和需求選擇合適的期刊。

歷年影響因子趨勢(shì)圖

發(fā)文數(shù)據(jù)

2023-2024 年國(guó)家/地區(qū)發(fā)文量統(tǒng)計(jì)

國(guó)家/地區(qū)數(shù)量
GERMANY (FED REP GER)139
USA96
England62
Australia57
Switzerland50
France44
Belgium41
Italy41
CHINA MAINLAND40
Spain33

本刊中國(guó)學(xué)者近年發(fā)表論文

1、Identification and analytical characterization of N-propyl norbutylone, N-butyl norbutylone, N-benzyl norheptedrone, and N-pyrrolidinyl-3,4-DMA
Author: Liu, Cui-Mei; Hua, Zhen-Dong; Song, Chun-Hui; Jia, Wei

Journal: DRUG TESTING AND ANALYSIS. 2023; Vol. 15, Issue 1, pp. 47-57. DOI: 10.1002/dta.3358
2、Identification of three novel new psychoactive substances 4F-AB-BUTINACA, AB-PHETINACA, and 2F-NENDCK
Author: Wang, Kua-Dou; Yuan, Xiao-Liang; Liu, Chen; Cao, Fang-Qi; Zhang, Yu-Rong; Liu, Wen-Bin; He, Si-Yang

Journal: DRUG TESTING AND ANALYSIS. 2023; Vol. 15, Issue 1, pp. 115-122. DOI: 10.1002/dta.3359
3、A multiplex qPCR assay for transgenes detection: A novel approach for gene doping control in horseracing using conventional laboratory setup
Author: Wong, Kin-Sing; Cheung, Hiu Wing; Szeto, Cherry W. L.; Tsang, Candice Y. N.; Wan, Terence S. M.; Ho, Emmie N. M.

Journal: DRUG TESTING AND ANALYSIS. 2023; Vol. , Issue , pp. -. DOI: 10.1002/dta.3483
4、In vitro and in vivo metabolism of 3-Methoxyeticyclidine in human liver microsomes, a zebrafish model, and two human urine samples based on liquid chromatography-high-resolution mass spectrometry
Author: Xu, Linhao; Liu, Xinze; Song, Zixuan; Xiang, Ping; Hang, Taijun; Yan, Hui

Journal: DRUG TESTING AND ANALYSIS. 2023; Vol. , Issue , pp. -. DOI: 10.1002/dta.3488
5、Identification of metabolites of evobrutinib in rat and human hepatocytes by using ultra-high performance liquid chromatography coupled with diode array detector and Q Exactive Orbitrap tandem mass spectrometry.
Author: Li Z¹, Zhang L¹, Yuan Y¹, Yang Z¹.

Journal: Drug Test Anal. 2019 Jan;11(1):129-139. doi: 10.1002/dta.2477. Epub 2018 Aug 29.
6、Metabolism of vesatolimod in rat, dog, and human liver microsomes: Metabolic stability assessment, metabolite identification, and interspecies comparison.
Author: Li W¹, Zhang J¹, Wang Y¹, Hu F¹, Zhang Y².

Journal: Drug Test Anal. 2019 Feb;11(2):240-249. doi: 10.1002/dta.2483. Epub 2018 Sep 17.
7、Inhibitory effect of isavuconazole, ketoconazole, and voriconazole on the pharmacokinetics of methadone in vivo and in vitro.
Author: Shen L¹, Wang J², Yi Y¹, Ye C¹, Wang R³, Xia G¹, Yu C¹, Tu F¹, Xu J¹, Zheng Z¹.

Journal: Drug Test Anal. 2019 Apr;11(4):595-600. doi: 10.1002/dta.2534. Epub 2018 Dec 25.
8、Pharmacokinetics of selegiline, R-methamphetamine, R-amphetamine, and desmethylselegiline in oral fluid after a single oral administration of selegiline.
Author: Chen L^1,², Shen B¹, Wang S³, Yu Y², Yan H¹, Shi Y¹, Duan G², Xiang P¹.

Journal: Drug Test Anal. 2019 Jan 6. doi: 10.1002/dta.2568. [Epub ahead of print]